09.07.2021 14:35:38
|
Eurofins, Rite Aid Launch FDA-authorised, At-home COVID-19 PCR Test Kit - Quick Facts
(RTTNews) - Eurofins Scientific (ERFSF.PK), through its empowerDX subsidiary, and Rite Aid announced Friday the launch of an over-the-counter, FDA-authorised, at-home COVID-19 PCR Test Kit.
The co-branded kits, available at all Rite Aid stores across 17 states in the U.S., will offer customers a convenient way to test for the virus from their home and will detect the virus in symptomatic and asymptomatic patients.
The at-home COVID-19 nasal PCR kit is among the first over-the-counter at-home test kits for SARS-CoV-2 to receive US Food and Drug Administration Emergency Use Authorization (EUA).
The test was developed by Eurofins Viracor, a leading infectious disease testing laboratory, and is based on its FDA EUA authorised SARS-CoV-2 RT-PCR assay.
As of December 2020, this later assay offers one of the best sensitivity rates of 117 laboratories that have submitted results to the FDA's SARS-CoV-2.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rite Aid Corp Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Rite Aid Corp Registered Shsmehr Analysen
Aktien in diesem Artikel
Rite Aid Corp Registered Shs | 0,70 | -74,26% |